Lillian Shaffer
Medical · Cullman, ALNPI 1154075752
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 358 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 25.7% of the total. Reporting peaked in 2023 at $3,032 and has fallen 60.4% since, to $1,201 in 2025. Among medical clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$1K
- Johnson & Johnson$956
- Lilly USA, LLC$732
- UCB, Inc.$614
- AstraZeneca$552
- plus $2K from 18 others
What the payments were for
- Food & beverage$8,10597%
- Education$2153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $2,136 |
| Amgen(2 entities) | 68 | $1,369 |
| Johnson & Johnson | 36 | $956 |
| Lilly USA, LLC | 25 | $732 |
| UCB, Inc. | 27 | $614 |
| AstraZeneca(2 entities) | 25 | $552 |
| Novartis | 25 | $425 |
| GSK | 23 | $419 |
| Pfizer | 12 | $212 |
| E.r. Squibb & Sons, L.L.C. | 4 | $129 |
| Mallinckrodt Hospital Products Inc. | 5 | $118 |
| ANI Pharmaceuticals, Inc. | 4 | $108 |
| Novo Nordisk | 1 | $100 |
| Sandoz | 4 | $90 |
| Radius Health, Inc. | 3 | $60 |
| Genentech USA, Inc. | 3 | $45 |
| Fresenius Kabi USA, LLC | 2 | $45 |
| Sobi, Inc | 2 | $42 |
| Celltrion USA Inc. | 2 | $41 |
| Organon | 2 | $34 |
| Boehringer Ingelheim | 1 | $34 |
| Sanofi | 1 | $22 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,321 in reported general payments places this provider in the 95th percentile of 175 medical providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz SyringeIxekizumab | 11 | $78,964 |
| Humira(Cf) PenAdalimumab | 11 | $74,927 |
| Hydroxychloroquine Sulfate | 215 | $11,593 |
| MethotrexateMethotrexate Sodium | 178 | $7,964 |
| Leflunomide | 30 | $4,233 |
| Duloxetine Hcl | 108 | $2,427 |
| Prednisone | 275 | $2,143 |
| Etodolac | 25 | $1,834 |
| Esomeprazole Magnesium | 11 | $1,617 |
| Celecoxib | 39 | $938 |
| Azathioprine | 16 | $772 |
| Baclofen | 46 | $727 |
| Cyclobenzaprine Hcl | 57 | $661 |
| Tizanidine Hcl | 57 | $576 |
| Sulfasalazine | 15 | $459 |
Paid to pharmacies, not to this prescriber.
Other medical in Cullman
- Lindsey MangumFlorence$44K
- Jaime DunnBirmingham$16K
- Stacy RichersonMobile$12K
- Susannah CashAuburn$11K
- Deana PorterAuburn$9K
- Rachel ThompsonFairhope$9K
- Shelley WinzelerHomewood$8K
- Reiga EvansHuntsville$8K
- Lauren TidwellHuntsville$8K
- Heidi EssigBirmingham$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.